BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 34485137)

  • 21. Nicotinamide phosphoribosyl-transferase/visfatin: a missing link between overweight/obesity and postmenopausal breast cancer? Potential preventive and therapeutic perspectives and challenges.
    Dalamaga M
    Med Hypotheses; 2012 Nov; 79(5):617-21. PubMed ID: 22922056
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of white blood cell count with breast cancer burden varies according to menopausal status, body mass index, and hormone receptor status: a case-control study.
    Park B; Lee HS; Lee JW; Park S
    Sci Rep; 2019 Apr; 9(1):5762. PubMed ID: 30962496
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Central obesity and breast cancer risk: a systematic review.
    Harvie M; Hooper L; Howell AH
    Obes Rev; 2003 Aug; 4(3):157-73. PubMed ID: 12916817
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Overweight, Obesity, and Postmenopausal Invasive Breast Cancer Risk: A Secondary Analysis of the Women's Health Initiative Randomized Clinical Trials.
    Neuhouser ML; Aragaki AK; Prentice RL; Manson JE; Chlebowski R; Carty CL; Ochs-Balcom HM; Thomson CA; Caan BJ; Tinker LF; Urrutia RP; Knudtson J; Anderson GL
    JAMA Oncol; 2015 Aug; 1(5):611-21. PubMed ID: 26182172
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Body fatness and endogenous sex hormones in the menopausal transition.
    Zsakai A; Karkus Z; Utczas K; Biri B; Sievert LL; Bodzsar EB
    Maturitas; 2016 May; 87():18-26. PubMed ID: 27013284
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Insulin-like growth factor-I (IGF-1), IGF-binding protein-3 (IGFBP-3) and mammographic features.
    Izzo L; Meggiorini ML; Nofroni I; Pala A; De Felice C; Meloni P; Simari T; Izzo S; Pugliese F; Impara L; Merlini G; Di Cello P; Cipolla V; Forcione AR; Paliotta A; Domenici L; Bolognese A
    G Chir; 2012 May; 33(5):153-62. PubMed ID: 22709450
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Obesity and adverse breast cancer risk and outcome: Mechanistic insights and strategies for intervention.
    Picon-Ruiz M; Morata-Tarifa C; Valle-Goffin JJ; Friedman ER; Slingerland JM
    CA Cancer J Clin; 2017 Sep; 67(5):378-397. PubMed ID: 28763097
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Structural equation model analysis for the evaluation of factors associated with overweight and obesity in menopausal women in RaNCD cohort study.
    Darbandi M; Najafi F; Pasdar Y; Rezaeian S
    Menopause; 2020 Feb; 27(2):208-215. PubMed ID: 31895176
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Obesity-associated Breast Cancer: Analysis of risk factors.
    Engin A
    Adv Exp Med Biol; 2017; 960():571-606. PubMed ID: 28585217
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Body size and breast cancer prognosis in relation to hormone receptor and menopausal status: a meta-analysis.
    Niraula S; Ocana A; Ennis M; Goodwin PJ
    Breast Cancer Res Treat; 2012 Jul; 134(2):769-81. PubMed ID: 22562122
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Energy balance, physical activity, and cancer risk.
    Fair AM; Montgomery K
    Methods Mol Biol; 2009; 472():57-88. PubMed ID: 19107429
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The relationship between body mass and breast cancer among women enrolled in the Cancer and Steroid Hormone Study.
    Chu SY; Lee NC; Wingo PA; Senie RT; Greenberg RS; Peterson HB
    J Clin Epidemiol; 1991; 44(11):1197-206. PubMed ID: 1941014
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Menopausal status does not predict Oncotype DX recurrence score.
    Carr DN; Vera N; Sun W; Lee MC; Hoover S; Fulp W; Acs G; Laronga C
    J Surg Res; 2015 Sep; 198(1):27-33. PubMed ID: 26095420
    [TBL] [Abstract][Full Text] [Related]  

  • 34.
    Lorenzo PM; Izquierdo AG; Diaz-Lagares A; Carreira MC; Macias-Gonzalez M; Sandoval J; Cueva J; Lopez-Lopez R; Casanueva FF; Crujeiras AB
    Front Endocrinol (Lausanne); 2020; 11():245. PubMed ID: 32390948
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Lipid profile comparison between pre- and post-menopausal women].
    Wang N; Qin MZ; Cui J
    Zhonghua Xin Xue Guan Bing Za Zhi; 2016 Sep; 44(9):799-804. PubMed ID: 27667280
    [No Abstract]   [Full Text] [Related]  

  • 36. Breast cancer risk in the WHI study: the problem of obesity.
    Kuhl H
    Maturitas; 2005 May; 51(1):83-97. PubMed ID: 15883113
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mechanisms underlying social inequality in post-menopausal breast cancer.
    Hvidtfeldt UA
    Dan Med J; 2014 Oct; 61(10):B4922. PubMed ID: 25283627
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Obesity and breast cancer risk.
    Pujol P; Galtier-Dereure F; Bringer J
    Hum Reprod; 1997 Oct; 12 Suppl 1():116-25. PubMed ID: 9403328
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of adipokines and cytokines in obesity-associated breast cancer: therapeutic targets.
    Khan S; Shukla S; Sinha S; Meeran SM
    Cytokine Growth Factor Rev; 2013 Dec; 24(6):503-13. PubMed ID: 24210902
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Body fat distribution and obesity in pre- and postmenopausal breast cancer.
    Sonnenschein E; Toniolo P; Terry MB; Bruning PF; Kato I; Koenig KL; Shore RE
    Int J Epidemiol; 1999 Dec; 28(6):1026-31. PubMed ID: 10661643
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.